A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection
CCR6 通过 APOBEC3G 的新型抗 HIV 活性:与中枢神经系统感染的相关性
基本信息
- 批准号:8293500
- 负责人:
- 金额:$ 0.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-29 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAnti-HIV AgentsAntiviral AgentsAntiviral TherapyAstrocytesBindingCCL20 geneCCL23 geneCCR6 geneCD4 Positive T LymphocytesCellsChemicalsClinicalCritical PathwaysDataDefensinsDendritic CellsDominant-Negative MutationEnzyme-Linked Immunosorbent AssayEpithelial CellsFlow CytometryHIVHIV InfectionsHIV SeropositivityInfectionKnowledgeLife Cycle StagesLigandsLymphaticMEKsMeasuresMediatingMicroarray AnalysisMicrogliaNeuraxisOrganPathway interactionsPatientsPeripheral Blood Mononuclear CellPertussis ToxinPhosphotransferasesPlayPreventionProgressive DiseaseProteinsReverse TranscriptionRoleSignal TransductionSmall Interfering RNASpecimenSymptomsT memory cellTestingTherapeuticViralVirusabstractingcell typechemokineinhibitor/antagonistinsightmacrophagemolecular massmutantnovelperipheral bloodpublic health relevancereceptorvirus host interaction
项目摘要
DESCRIPTION (provided by applicant): A novel anti-HIV activity of CCR6 via APOBEC3G: relevance to CNS infection Abstract We have shown that when defensin hBD2 and chemokine MIP-31 (CCL20) bind to their cellular receptor, CCR6, they induce an intracellular antiviral activity against HIV that is absent in cells that do not express CCR6. While direct inactivation of enveloped viruses including HIV has been implicated as one mechanism of defensins, to our knowledge, HIV inhibition mediated through CCR6 is novel. The mechanism occurs post entry but at or before reverse transcription, and appears to be due to increased expression of the intracellular antiviral protein APOBEC3G. Inhibition is abrogated by pertussis toxin, suggesting the involvement of G1i-dependent signal transduction. CCR6 is expressed on cells that are highly relevant to HIV infection; they include memory T cells, dendritic cells, activated macrophages, microglia and Th17 cells. Defensins that bind to CCR6 are primarily expressed by epithelial cells and astrocytes, while MIP-31 is produced by mucosal epithelial cells, activated peripheral blood mononuclear cells and astrocytes. Since both CCR6 and its ligands are expressed in the central nervous system in cells highly relevant to HIV infection, an HIV suppressive mechanism that targets CCR6 may play a critical role in controlling HIV infection and CNS symptoms. Further, elucidation of the intracellular pathways and the step(s) in the HIV life-cycle limited by CCR6 activation could provide insights into virus-host interactions early in infection and identify new targets for antiviral therapy. We propose to identify APOBEC3G as the effector molecule of the antiviral activity mediated by CCR6 in primary cells; to demonstrate that CCR6- induced signal transduction increases APOBEC3G expression and identify what is the critical specific pathway; to demonstrate the efficacy of CCR6-mediated HIV inhibition on a broad spectrum of primary and non-B viral isolates; and to measure the expression of CCR6, CCR6 ligands, and APOBEC3G in clinical specimens.
PUBLIC HEALTH RELEVANCE: The studies proposed here will investigate the mechanism of inhibition of HIV by a cellular receptor called CCR6. These studies are highly relevant to prevention and treatment of HIV infection because they will contribute knowledge that can be used to develop novel anti-HIV drugs that will target CCR6.
摘要:我们已经证明,当防御蛋白hBD2和趋化因子MIP-31 (CCL20)结合到它们的细胞受体CCR6上时,它们会诱导细胞内抗HIV病毒的抗病毒活性,这种活性在不表达CCR6的细胞中是不存在的。虽然包括HIV在内的包膜病毒的直接失活已被认为是防御素的一种机制,但据我们所知,通过CCR6介导的HIV抑制是一种新的机制。这种机制发生在细胞进入后,但在逆转录时或之前,似乎是由于细胞内抗病毒蛋白APOBEC3G的表达增加。百日咳毒素消除了抑制作用,提示g1依赖性信号转导的参与。CCR6在与HIV感染高度相关的细胞上表达;它们包括记忆T细胞、树突状细胞、活化巨噬细胞、小胶质细胞和Th17细胞。与CCR6结合的防御素主要由上皮细胞和星形胶质细胞表达,而MIP-31则由粘膜上皮细胞、活化的外周血单核细胞和星形胶质细胞产生。由于CCR6及其配体均在与HIV感染高度相关的中枢神经系统细胞中表达,因此针对CCR6的HIV抑制机制可能在控制HIV感染和中枢神经系统症状中发挥关键作用。此外,阐明细胞内通路和受CCR6激活限制的HIV生命周期中的步骤可以为感染早期病毒-宿主相互作用提供见解,并确定抗病毒治疗的新靶点。我们建议在原代细胞中鉴定APOBEC3G作为CCR6介导的抗病毒活性的效应分子;证明CCR6诱导的信号转导增加APOBEC3G的表达,并确定什么是关键的特异性途径;证明ccr6介导的HIV抑制对原发和非b病毒分离物的广谱有效性;检测CCR6、CCR6配体、APOBEC3G在临床标本中的表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alfredo Garzino-Demo其他文献
Alfredo Garzino-Demo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alfredo Garzino-Demo', 18)}}的其他基金
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection
CCR6 通过 APOBEC3G 的新型抗 HIV 活性:与中枢神经系统感染的相关性
- 批准号:
7840803 - 财政年份:2009
- 资助金额:
$ 0.97万 - 项目类别:
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection
CCR6 通过 APOBEC3G 的新型抗 HIV 活性:与中枢神经系统感染的相关性
- 批准号:
8319412 - 财政年份:2009
- 资助金额:
$ 0.97万 - 项目类别:
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection
CCR6 通过 APOBEC3G 的新型抗 HIV 活性:与中枢神经系统感染的相关性
- 批准号:
8529631 - 财政年份:2009
- 资助金额:
$ 0.97万 - 项目类别:
A Novel Anti-HIV Activity of CCR6 via APOBEC3G: Relevance to CNS Infection
CCR6 通过 APOBEC3G 的新型抗 HIV 活性:与中枢神经系统感染的相关性
- 批准号:
8128430 - 财政年份:2009
- 资助金额:
$ 0.97万 - 项目类别:
相似海外基金
Development of anti-HIV agents with dual mechanisms of actions based on triterpenoids as drug discovery templates
以三萜类化合物为药物发现模板,开发具有双重作用机制的抗 HIV 药物
- 批准号:
15K07998 - 财政年份:2015
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of anti-HIV agents targeting weak points of viral replication mechanism
针对病毒复制机制的弱点开发抗HIV药物
- 批准号:
26670053 - 财政年份:2014
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8466077 - 财政年份:2012
- 资助金额:
$ 0.97万 - 项目类别:
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8777085 - 财政年份:2012
- 资助金额:
$ 0.97万 - 项目类别:
Development of anti-HIV agents that exert synergism with host immune pressure
开发与宿主免疫压力发挥协同作用的抗HIV药物
- 批准号:
24390254 - 财政年份:2012
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Design and synthesis of anti-HIV agents that inhibit the Pr55Gag membrane localization
抑制 Pr55Gag 膜定位的抗 HIV 药物的设计和合成
- 批准号:
24790124 - 财政年份:2012
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Structure activity and structure property relationships for novel anti-HIV agents
新型抗HIV药物的结构活性和结构性质关系
- 批准号:
8588784 - 财政年份:2012
- 资助金额:
$ 0.97万 - 项目类别:
Developing host defense peptides as novel anti-HIV agents
开发宿主防御肽作为新型抗 HIV 药物
- 批准号:
230278 - 财政年份:2011
- 资助金额:
$ 0.97万 - 项目类别:
Fellowship Programs
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
设计和合成抑制 Vif 介导的 APOBEC3G 蛋白酶体降解的抗 HIV 药物
- 批准号:
22659024 - 财政年份:2010
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of anti-HIV agents using chemical genomics based on viral self-regulation mechanism
基于病毒自我调节机制的化学基因组学抗HIV药物的开发
- 批准号:
22659021 - 财政年份:2010
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research